NCT02187224View on ClinicalTrials.gov

Progesterone Effect on Individuals Diagnoses With AD and PTSD.

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 1, 2016

Primary Completion Date

September 8, 2021

Study Completion Date

September 8, 2021

Conditions
Alcohol DependencePost-Traumatic Stress Disorder (PTSD)
Interventions
DRUG

Progesterone

DRUG

Placebo (for Progesterone)

Trial Locations (1)

06516

VA Connecticut Healtcase System, West Haven

Sponsors
All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Brain & Behavior Research Foundation

OTHER

lead

Yale University

OTHER